 Momenta Pharmaceuticals, Inc. NASDAQ:MNTA has been given an average recommendation of Buy by the eleven ratings firms that are currently covering the firm, Marketbeat Ratings reports. Two analysts have rated the stock with a hold rating, eight have issued a buy rating and one has assigned a strong buy rating to the company. The average ... 